2019 Fall Conference | C22 - Neurology Update 7: Sleep and Neuro-infectious Disease
Program Materials Program Evaluations
07:30 AM - 08:15 AM | Speaker |
Sleep
Logan D. Schneider, MD |
08:15 AM - 09:00 AM | Speaker |
Neuro-infectious Disease
Allen J. Aksamit, Jr., MD, FAAN |
Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |
Nancy J. Newman, MD, FAAN | Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
Neeraj Kumar, MD | Dr. Kumar has nothing to disclose. |
Logan D. Schneider, MD | Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care. |